Increase in acute mastoiditis at the end of the COVID-19 pandemic

Eva Goldberg-Bockhorn1, Clara Hurzlmeier2, Julius M Vahl2

  • 1Department of Otorhinolaryngology, Head and Neck Surgery, Ulm University Medical Center, Frauensteige 12, 89075, Ulm, Germany. eva.goldberg@uniklinik-ulm.de.

Abstract

Insights

Non-pharmaceutical interventions (NPI) during COVID-19 significantly reduced acute mastoiditis (AM) cases. Their removal led to a sharp increase in AM incidence, particularly in children, possibly due to increased viral infections and a less-trained immune system.

Area of Science:

  • Otolaryngology
  • Infectious Diseases
  • Epidemiology

Background:

  • Non-pharmaceutical interventions (NPI) during the COVID-19 pandemic reduced common respiratory infections.
  • The withdrawal of NPI has been linked to increased respiratory infections, especially in otorhinolaryngology.
  • Acute mastoiditis (AM) is a significant ear infection requiring study regarding pandemic-related influences.

Purpose of the Study:

  • To evaluate the impact of NPI during the COVID-19 pandemic on the incidence and severity of acute mastoiditis (AM).

Main Methods:

  • Retrospective study comparing pre-pandemic (2011-2019) and pandemic/post-pandemic (2020-2023) data.
  • Analysis included seasonal patterns, age-specific differences, pathogens, and complication rates.
  • Data collected from a German third-level hospital.

Main Results:

  • 196 AM cases analyzed; 133 were children (1-5 years old).
  • AM complications were more frequent in adults (87%) than children (17%).
  • Post-pandemic, a rise in AM cases occurred after NPI cessation, with *Streptococcus pyogenes* noted in children.

Conclusions:

  • NPI effectively reduced AM incidence during the COVID-19 pandemic.
  • Reversal of NPI led to a substantial increase in AM incidence.
  • This rise may be linked to increased viral respiratory infections and reduced immune system training.